Inhibition of nitric oxide synthesis by systemic N(G)-monomethyl-L- arginine administration in humans: Effects on interstitial adenosine, prostacyclin and potassium concentrations in resting and contracting skeletal muscle

Journal of Vascular Research

Volumn 37, Issue 4, 2000, Pages 297-302

  Frandsen, Ulrik ^b   Bangsbo, Jens ^b   Langberg, Henning ^b   Saltin, Bengt ^b   Hellsten, Ylva ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

Blood flow regulation; Exercise; Nitric oxide; Prostaglandin; Skeletal muscle

Indexed keywords

ADENOSINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM; PROSTACYCLIN;

ADULT; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; ENZYME INHIBITION; EXERCISE; HUMAN; HUMAN EXPERIMENT; INTERSTITIAL FLUID; LEG BLOOD FLOW; MALE; MICRODIALYSIS; MUSCLE CONTRACTION; NORMAL HUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0033798760     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025743     Document Type: Article

References (35)

1. Wilson JR, Kapoor S: Contribution of endothelium-derived relaxing factor to exercise-induced vasodilation in humans. J Appl Physiol 1993;79:2740-2744.
2. Brett SE, Cockcroft JR, Mant TGK, Ritter JM, Chowienczyk PJ: Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise. J Hypertens 1998; 16:29-435.
3. Koller SJ, Eichler HG, Wolzt M, Muller M, Entlicher J, Eichler HG, Schmetterer L: Role of nitric oxide in exercise induced vasodilation in man. Life Sci 1998;61:1035-1042.
4. Rådegran G, Saltin B: Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol 1999;276:H1951-H1960.
5. Gilligan DM, Panza JA, Crescence MA, Waclawiw MA, Casino PR, Quyyumi AA: Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1994; 90:2853-2858.
6. Nakane M, Schmidt HHHW, Pollock JS, Förstermann U, Murad F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993;316:175-180.
7. Frandsen U, Lopez-Figueroa M, Hellsten Y: Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun 1996;227:88-93.
8. Roberts CK, Barnard J, Jasman A, Balon TW: Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol 1999; 277:E390-E394.
9. Balon TW, Nadler JL: Nitric oxide release is present from incubated skeletal muscle preparations. J Physiol (Lond) 1994;77:2519-2521.
10. 3 concentrations in the interstitial fluid of resting and contracting human skeletal muscle: Effects of AMP and norepinephrine infusion. Physiologist 1998;41/4:267.
11. Dobson JG, Rubio R, Berne M: Role of adenine nucleotides, adenosine and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res 1971;29:375-384.
12. Rådegran G: Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 1997;83:1383-1388.
13. Hellsten Y, Maclean D, Rådegran G, Saltin B, Bangsbo J: Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation 1998;98/1:6-8.
14. Bunting S, Gryglewski R, Moncada S, Vane JR: Arterial walls generate from prostagladin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976;12:565-574.
15. Duffy SJ, New G, Tran BT, Harper RW, Meredith IT: Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 1999;276: H663-H670.
16. Dusting GJ, Moncada S, Vane JR: Vascular actions of archidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog. Eur J Pharmacol 1978;49:65-72.
17. Smith EF, Ogletree ML, Sherwin JR. Lefer AM: Effects of prostagladins on distribution of blood flow in the cat. Prostaglandins Med 1978;1:411-418.
18. Wilson JR, Kapoor SC, Krishna GG: Contribution of potassium to exercise-induced vasodilation in humans. J Physiol 1994;77:2552-2557.
19. + in human skeletal muscle during and after dynamic graded exercise determined by microdialysis. Am J Physiol 2000;278: R400-R406.
20. Tayama S, Okumura T, Matsunaga T, Tsunoda R, Tabuchi, T, Iwasa, A, Yasue H: Influence of chronic nitric oxide inhibition of coronary blood flow regulation. Jpn Circ J 1998;62:371-378.
21. Tomohiro O, Fujita N, Fujiwara N, Nakano T. Takahashi K, Guan W, Okumura K: Cross-talk of shear-induced production of prostacyclin and nitric oxide in endothclial cells. Am J Physiol 2000;278:H233-H238.
22. Puybasset L, Bea ML, Ghalch B, Giudicelli JF, Berdeaux A: Coronary and systemic haemodynamic effecs of sustained inhibition of nitric oxide synthesis in concious dogs: Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels. Circ Res 1996;79: 343-357.
23. Andersen P, Adams RP, Sjøgaard G, Thorboc A, Saltin B: Dynamic knee extension as a model for the study of an isolated exercising muscle in man. J Appl Physiol 1985;59:1647-1653.
24. Rådegran G, Pilegaard H, Nielscn JJ, Bangsbo J: Microdialysis ethanol removal reflects probe recovery rather than local blood flow in skeletal muscle. J Appl Physiol 1998;85:751-757.
25. Nitsch J, Steinbeck G, Luderitz B: Comparison of myocardial potassium and thallium flux as studied by tracer methods. Clin Cardiol 1980; 3:188-191.
26. Scheller D, Kolb J: The internal reference technique in microdialysis: A practical approach to monoloring dialysis effiency and to calculating tissue concentration from dialysate samples. J Ncurosci Methods 1991;40:31-38.
27. Andersen P, Saltin B: Maximal perfusion of skeletal muscle in man. J Physiol (Lond) 1985: 366:233-249.
28. Tullson P, Bangsbo J, Hellsten Y, Richter E: IMP metabolism in human skeletal muscle following exhaustive exercise. J Appl Physiol 1995;78:146-152.
29. Shoemaker JK, Halliwell JR, Hughson RL, Joyner MJ: Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol 1997;273: H2388-H2395.
30. McCulloch AI, Bottrill FE, Randall MD, Hiley CR: Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 1997;120:1431-1438.
31. Félétou M, Vanhoutte PM: Endothelian dysfunction: A novel therapeutic target. The alternative: EDRF. J Moll Cell Cardiol 1999;31:15-22.
32. Salmon JA, Smith DR, Flower RJ, Moncada S, Vane JR: Further studies on the enzymatic conversion of prostaglandins endoperoxide into prostacyclin by porchine aorta microsomes. Biochim Biophys Acta 1978;523:250-262.
33. Steinberg H, Mevedev OS, Luft FC, Unger T: Effect of a prostacyclin derivative (iloprost) on regional blood flow, sympathetic nerve activity, and baroreceptor reflex in the conscious rat. J Cardiovasc Pharmacol 1988;11:84-89.
34. Bangsbo J, Hellsten Y: Muscle blood flow and oxygen uptake in recovery from exercise. Acta Physiol Scand 1998;162:305-312.
35. Langberg H, Skovgaard D, Karamouzis M, Bülow J, Kjær M: Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J Physiol 1999;515:919-927.